CSBR
NASDAQ
US
Champions Oncology, Inc. - Common Stock
$5.77
▼ $-0.15
(-2.53%)
Vol 3K
11
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$96.0M
P/E
32.5
ROE
87.9%
Margin
5.2%
D/E
5.19
Beta
0.32
52W
$6–$12
Wall Street Consensus
7 analysts · Apr 20262
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $0.09 | $-0.02 | $-0.11 |
| Dec 2025 | $0.01 | $0.02 | +$0.01 |
| Sep 2025 | $-0.01 | $0.02 | +$0.03 |
| Jun 2025 | $-0.20 | $-0.07 | +$0.13 |
Quarterly Revenue & Earnings
| Quarter | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… | 2026-0… |
|---|---|---|---|---|---|---|
| Revenue | — | $17.0M | $12.4M | $14.0M | $15.0M | $16.6M |
| Net Income | — | $4.5M | -$1.8M | -$466K | $299K | -$279K |
Fundamentals Trend
| Metric | 2025-07-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 87.9% | 102.4% | 87.9% | 87.9% | 87.9% | 87.9% |
| P/E (TTM) | 29.50 | 21.38 | 30.59 | 31.95 | 28.10 | 32.50 |
| Net Margin | -3.1% | 8.3% | 5.2% | 5.2% | 5.2% | 5.2% |
| Gross Margin | 42.9% | 50.1% | 48.5% | 48.5% | 48.5% | 48.5% |
| D/E Ratio | 5.19 | 5.83 | 5.19 | 5.19 | 5.19 | 5.19 |
| Current Ratio | 0.93 | 0.94 | 0.93 | 0.93 | 0.93 | 0.93 |
Key Ratios
ROA (TTM)
9.9%
P/S (TTM)
1.69
P/B
26.2
EPS (TTM)
$0.20
CF/Share
$-0.32
Rev Growth 3Y
+5.1%
52W High
$11.99
52W Low
$5.59
$5.59
52-Week Range
$11.99
Financial Health
Free Cash Flow
-$1.4M
Net Debt
-$2.2M
Cash
$7.1M
Total Debt
$4.9M
As of Jan 31, 2026
How does CSBR compare to Life Sciences Tools & Services peers?
Peer group: Micro-cap Life Sciences Tools & Services (All) · 44 companies
CSBR valuation vs Life Sciences Tools & Services peers
P/E ratio
32.5
▲
0%
above
peers
(32.5)
vs Peers
vs Industry
Undervalued
P/S ratio
1.7
▼
55%
below
peers
(3.7)
vs Peers
vs Industry
Undervalued
P/B ratio
26.2
▲
1230%
above
peers
(2.0)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.5%)
vs Peers
vs Industry
Low yield
CSBR profitability vs Life Sciences Tools & Services peers
ROE
87.9%
▲
456%
above
peers
(-24.7%)
vs Peers
vs Industry
Top tier
Net margin
5.2%
▲
119%
above
peers
(-27.8%)
vs Peers
vs Industry
Top tier
Gross margin
48.5%
▲
0%
above
peers
(48.2%)
vs Peers
vs Industry
In line
ROA
9.9%
▲
168%
above
peers
(-14.6%)
vs Peers
vs Industry
Top tier
CSBR financial health vs Life Sciences Tools & Services peers
D/E ratio
5.2
▼
78%
below
peers
(23.2)
vs Peers
vs Industry
Above avg
Current ratio
0.9
▼
72%
below
peers
(3.3)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼
76%
below
peers
(1.4)
vs Peers
vs Industry
More volatile
CSBR fundamentals radar
CSBR
Peer median
Industry
CSBR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CSBR vs peers: key metrics
Related Signals
Top Holders
Top 5: 36.14%Battery Management Corp.
17.44%
$13.9M
NEA Management Company, LLC
12.34%
$9.8M
Vanguard Group Inc
2.41%
$1.9M
Tocqueville Asset Managemen…
2.30%
$1.8M
Morgan Stanley
1.65%
$1.3M
As of Dec 31, 2025
Latest News
No related news yet